You have no items in your shopping cart.
Search results for: 'cancer protein'
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 35.3 KDa. Observed: 40-47 KDa, reducing conditions
Human
Gly32-Val351
C-6His
500 μg, 1 mg, 10 μg, 50 μgUnconjugated
SDS-PAGE: Greater than 85% as determined by reducing SDS-PAGE.
Predicted: 23.9 KDa. Observed: 30 KDa, reducing conditions
Human
Ser627-Ser837
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 42.9 KDa. Observed: 60-75 KDa, reducing conditions
Cynomolgus
Leu25-Gln167
C-Fc
500 μg, 10 μg, 50 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 11.4 KDa. Observed: 16 KDa, reducing conditions
Human
Ser101-Lys198
Tag free
10 μg, 500 μg, 1 mg, 50 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 13.6 KDa. Observed: 16-18 KDa, reducing conditions
Human
Met1-Asp127
Tag free
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 80% as determined by reducing SDS-PAGE.
Predicted: 61.5 KDa. Observed: 62 KDa, reducing conditions
Human
Met1-Asp552
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 21.8 KDa. Observed: 19&46 KDa, reducing conditions
Human
Met1-Asn175
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 20.5 KDa. Observed: 18 KDa, reducing conditions
Human
Met1-Arg165
N-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 30.58 KDa. Observed: 32 KDa, reducing conditions
Human
Met1-Asn244
N-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 90% as determined by SEC-HPLC. (QC verified)
Predicted: 42 KDa. Observed: 60 KDa, reducing conditions
Human
Pro21-Gln167
C-mFc
10 μg, 50 μg, 500 μg, 1 mg
